Erratum: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206)

S. Bomken; L. Buechler; K. Rehe; F. Ponthan; A. Elder; H. Blair; C. M. Bacon; J. Vormoor; O. Heidenreich

doi:10.1038/leu.2013.113

Erratum: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206)

S. Bomken, L. Buechler, K. Rehe, F. Ponthan, A. Elder, H. Blair, C. M. Bacon, J. Vormoor, O. Heidenreich

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1792
Number of pages	1
Journal	Leukemia
Volume	27
Issue number	8
DOIs	https://doi.org/10.1038/leu.2013.113
Publication status	Published - Aug 2013
Externally published	Yes

Access to Document

10.1038/leu.2013.113

Cite this

Bomken, S., Buechler, L., Rehe, K., Ponthan, F., Elder, A., Blair, H., Bacon, C. M., Vormoor, J., & Heidenreich, O. (2013). Erratum: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206). Leukemia, 27(8), 1792. https://doi.org/10.1038/leu.2013.113

@article{2531ad52707f4d0fb7d3d0db25b09614,

title = "Erratum: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206)",

author = "S. Bomken and L. Buechler and K. Rehe and F. Ponthan and A. Elder and H. Blair and Bacon, \{C. M.\} and J. Vormoor and O. Heidenreich",

year = "2013",

month = aug,

doi = "10.1038/leu.2013.113",

language = "English",

volume = "27",

pages = "1792",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

Bomken, S, Buechler, L, Rehe, K, Ponthan, F, Elder, A, Blair, H, Bacon, CM, Vormoor, J & Heidenreich, O 2013, 'Erratum: Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206)', Leukemia, vol. 27, no. 8, pp. 1792. https://doi.org/10.1038/leu.2013.113

TY - JOUR

T1 - Erratum

T2 - Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression (Leukemia (2013) 27 (718-721) DOI: 10.1038/leu.2012.206)

AU - Bomken, S.

AU - Buechler, L.

AU - Rehe, K.

AU - Ponthan, F.

AU - Elder, A.

AU - Blair, H.

AU - Bacon, C. M.

AU - Vormoor, J.

AU - Heidenreich, O.

PY - 2013/8

Y1 - 2013/8

UR - https://www.scopus.com/pages/publications/84881410137

U2 - 10.1038/leu.2013.113

DO - 10.1038/leu.2013.113

M3 - Comment/debate

AN - SCOPUS:84881410137

SN - 0887-6924

VL - 27

SP - 1792

JO - Leukemia

JF - Leukemia

IS - 8

ER -